Ocugen (OCGN) Share-based Compensation Growth (3y) (2017 - 2026)
Ocugen (OCGN) Share-based Compensation Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 8.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.11% |
| Dec 31, 2025 | -35.60% |
| Sep 30, 2025 | -7.48% |
| Jun 30, 2025 | -19.02% |
| Mar 31, 2025 | -17.02% |
| Dec 31, 2024 | -49.48% |
| Sep 30, 2024 | 11.99% |
| Jun 30, 2024 | -3.24% |
| Mar 31, 2024 | 28.34% |
| Dec 31, 2023 | 73.63% |
| Sep 30, 2023 | 158.40% |
| Jun 30, 2023 | 160.44% |
| Mar 31, 2023 | 129.66% |
| Dec 31, 2022 | 78.69% |
| Sep 30, 2022 | 134.69% |
| Jun 30, 2022 | 164.93% |
| Mar 31, 2022 | 99.55% |
| Dec 31, 2021 | 176.65% |
| Sep 30, 2021 | -18.63% |
| Jun 30, 2021 | 72.52% |